News Release Mr. David Brennan of AstraZeneca Elected President of IFPMA New Vice Presidents are Mr. John Lechleiter of Lilly and Mr. Masafumi Nogimori of Astellas Washington DC, 10 November 2010 –The International Fed

First Page		Document Content
Date: 2013-06-30 20:56:25 Pharmacy Pharmaceutical industry IFPMA Pharmaceutical Research and Manufacturers of America AstraZeneca European Federation of Pharmaceutical Industries and Associations International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Zeneca Eli Lilly and Company Pharmaceutical sciences Pharmaceuticals policy Pharmacology		News Release Mr. David Brennan of AstraZeneca Elected President of IFPMA New Vice Presidents are Mr. John Lechleiter of Lilly and Mr. Masafumi Nogimori of Astellas Washington DC, 10 November 2010 –The International Fed Add to Reading List Source URL: www.jpma.or.jp Download Document from Source Website File Size: 48,22 KB Share Document on Facebook

	Greg Perry, Assistant Director General, IFPMA Currently, IFPMA is the industry interlocutor globally with 50 associations and 40 companies, and focuses on four priority areas: (1) Innovation ecosy DocID: 1uQEk - View Document
	IFPMA COMPETITION GUIDANCE COMMITMENT IFPMA and its member associations and member companies (hereinafter “Members”) are committed to conducting trade association activities in compliance with applicable competition DocID: 1u1i4 - View Document
	AstraZeneca Trade Association Memberships Country / Region Name of Association Global Trade Associations IFPMA (International Federation of Pharmaceutical DocID: 1sOwt - View Document
	IFPMA Code of Pharmaceutical Marketing Practices DocID: 1qll3 - View Document
	DEVELOPING WORLD HEALTH PARTNERSHIPS DIRECTORY OVER 25 0 H EA LTH PART N E R S H I P S T H AT MA K E A DIF F ERENCE TO P E O P L E ’ S L I V E S DocID: 1nXid - View Document